In Alzheimer’s disease, the involvement of IFN-γ is well established [32], although ambiguous, since IFN-γ infusion shows both enhanced neurogenesis and aggravated pathology in transgenic mice models [33–35]. This evidence concerns the gene IFNG and early-onset autosomal dominant Alzheimer disease.